Anti-Neoplastics Flashcards
What is the mechanism of Alkylating Agents?
- Introduce alkyl groups in DNA (most important), RNA, and/or proteins.
- Causes DNA crosslinks, strand breaks, code misreading
- Least selective of antineoplastics
What is the cell cycle specificity of Alkylating Agents?
- Some cell-cycle nonspecific (also affects G0 cells)
e. g. mechlorethamine, carmustine - Some cycle-specific phase-nonspecific (spares G0)
e. g. cyclophosphamide
Name five classes of alkylating agents
- Nitrogen Mustards
- Alkyl Sulfonates
- EthylEnimines/MethylMelamines (E & E, M & M)
- Nitrosoureas
- Triazenes
Mechlorethamine
Class: Alkylating Agent (Nitrogen Mustard). Cycle-nonspecific
Use: Prototype - limited use today. Lymphomas (incl. Hodgkin’s), breast, lung, ovarian CA
Kinetics: Gone from blood in seconds to minutes, no CNS penetrance
Route: IV
S/E: N/V, Myelosuppression, mild Alopecia
Cyclophosphamide
Class: Alkylating Agent (Nitrogen Mustard). Cycle-specific phase-nonspecific
Use: Broad spectrum. Most used agent in this class
Kinetics: Prodrug, activated by P450s. Poor CNS penetration
Route: Oral or parenteral
S/E: Sterile hemorrhagic cystitis (bladder toxicity), N/V, Alopecia, limited Myelosuppression
Mesna
Use: Organosulfur compound given to reduce bladder toxicity from toxic byproducts of cyclophosphamide activation (acrolein)
Carmustine
Class: Alkylating Agent (Nitrosourea). Cycle-nonspecific
Use: Brain tumors, multiple myeloma, melanoma
Kinetics: Excellent CNS penetration
S/E: N/V, delayed Myelosuppression
What are common properties of Antimetabolite Antineoplastics?
- Structural analogs of compounds required in metabolism
- Falsely substitute in place of natural compound
- Most effective in tumors with rapid cell proliferation, thus:
- S PHASE SPECIFIC
Methotrexate (MTX)
Class: Antimetabolite
Action: Binds dihydrofolate reductase (DHFR), blocking FH2 + dTMP –> FH4. CA cells also polymerize MTX to MTX-polyglutamate (a MORE potent DHFR inhibitor) more than normal cells
Use: ALL, choriocarcinoma, others
S/E: RENAL TUBULAR NECROSIS, N/V, intestinal epithelia damage, marrow suppression
Interactions: Displaces other drugs from serum albumin
Leucovorin
AKA folinic acid - fully reduced folate (does not need DHFR). Normal cells can internalize Leucovorin more than CA cells, so is used to rescue host cells following MTX inhibition of DHFR.
5-Fluorouracil (5-FU)
Class: Antimetabolite
Action: Pyrimidine analog. Activated to FUTP (inhibits RNA synth) and FdUMP (inhibits thymidylate synth and therefore DNA synth)
Use: Broad spectrum, esp colon, breast, basal cell carcinoma
S/E: N/V, Anorexia, Diarrhea, Myelosuppression
Cytarabine (Ara-C)
Class: Antimetabolite
Action: Cytidine analog. Competes for phosphorylation with cytidine. Causes chain termination when integrated into DNA.
Use: Acute leukemias, ESPECIALLY AML. Lymphomas, head, neck
Kinetics: Given 2x/day for ~5 days - long infusion increases probability of killing CA cells not initially in S-phase. Afterwards, rapidly cleared.
S/E: DOSE-LIMITING myelosuppression, NEUROTOXICITY
6-Mercaptopurine (6-MP)
Class: Antimetabolite
Action: Purine analog. Activated in cells, inhibits RNA & DNA synth.
Use: ACUTE LEUKEMIAS, chronic granulocytic leukemia
Kinetics: Metabolized by TPMT. Special considerations for pts with dysfunctional TPMT.
S/E: gradual marrow suppression, N/V, anorexia, JAUNDICE
Thiopurine Methyltransferase
AKA TPMT. Important in 6-MP administration. Pts w/ 1 copy of nonfunctional TPMT - markedly reduced dose. Pts w/ 2 copies of nonfunctional TPMT CANNOT TOLERATE 6-MP. Too much 6-MP = serious marrow toxicity
Hydroxyura
Class: Antimetabolite
Action: Inhibits RIBONUCLEOTIDE REDUCTASE (blocks ribonucleotides –> dNTPs), inhibiting DNA synth. Arrests cells at G1-S interface!
Note: Often used w/ radiation, as cells need dNTPs to repair radiation DNA damage.
Use: GRANULOCYTIC LEUKEMIA, head, neck
S/E: Marrow suppression, GI effects